Fibrosin-like 1 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, which are essential for various signaling pathways. Inhibition of these kinases by Staurosporine can lead to a decrease in phosphorylation events that are necessary for the activity of Fibrosin-like 1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinases (PI3K), which are upstream in cell survival and growth pathways. PI3K inhibition can reduce the activity of downstream effectors that are likely to be involved in the regulation or stabilization of Fibrosin-like 1 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is another PI3K inhibitor, similar to Wortmannin, and it can hinder the PI3K/AKT pathway, potentially leading to decreased activity of pathways that Fibrosin-like 1 may be involved in, thus functionally inhibiting Fibrosin-like 1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin selectively inhibits mTOR (mechanistic target of rapamycin), which is a central molecule in regulating cell growth and metabolism. Inhibition of mTOR can disrupt activities and pathways that Fibrosin-like 1 is involved in, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 specifically inhibits p38 MAP Kinase, which is involved in inflammatory responses and cell differentiation. Inhibition of p38 MAPK might disrupt signaling pathways that are crucial for the functional activity of Fibrosin-like 1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is an inhibitor of MEK, which is upstream of the ERK pathway, a key pathway for cell proliferation and differentiation. Inhibition of MEK can lead to reduced ERK activity, indirectly leading to functional inhibition of Fibrosin-like 1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK (c-Jun N-terminal kinase), which is implicated in stress responses and apoptosis. By inhibiting JNK, SP600125 might interfere with signaling pathways that Fibrosin-like 1 is a part of, resulting in its functional inhibition. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor, which can inhibit Src family kinases and other kinases, potentially affecting multiple signaling pathways that could be involved in the regulation of Fibrosin-like 1 function, leading to its inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. By inhibiting Src kinases, PP2 can disrupt signaling pathways that may be essential for the activity of Fibrosin-like 1, therefore functionally inhibiting it. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK, which is upstream of the ERK pathway. By inhibiting MEK, PD98059 can reduce ERK signaling, which may play a role in pathways involving Fibrosin-like 1, leading to its functional inhibition. | ||||||